Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
10.03
-0.27 (-2.62%)
At close: Nov 16, 2026, 4:00 PM EST
10.18
+0.15 (1.50%)
After-hours: Nov 16, 2026, 7:30 PM EST

Keros Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
259.46287.42559.93331.15279.05230.04
Cash & Short-Term Investments
259.46287.42559.93331.15279.05230.04
Cash Growth
-62.59%-48.67%69.09%18.67%21.30%-13.48%
Accounts Receivable
203.572.740.14-18
Other Receivables
3.4217.291.710.950.840.2
Receivables
23.4220.854.461.090.8418.2
Prepaid Expenses
2.12.761.761.642.281.38
Other Current Assets
2.654.422.7413.423.61.82
Total Current Assets
287.63315.43588.89347.29285.77251.44
Property, Plant & Equipment
18.2821.1423.4919.4717.572.4
Other Long-Term Assets
1.461.453.513.263.451.41
Total Assets
307.37338.02615.89370.03306.78255.25

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.791.974.65.453.343.65
Accrued Expenses
8.4512.4520.4517.25127.03
Current Portion of Leases
2.72.411.981.010.460.86
Current Income Taxes Payable
0.623.38---0.11
Other Current Liabilities
0.320.220.420.670.750.2
Total Current Liabilities
15.8620.4127.4524.3716.5511.85
Long-Term Leases
12.4214.4816.8813.4412.810.23
Total Liabilities
28.2734.8944.3337.8129.3612.08

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000
Additional Paid-In Capital
1,1851,1691,140713.64505.86366.93
Retained Earnings
-520.03-481.77-568.78-381.43-228.43-123.76
Treasury Stock
-386.21-384.56----
Total Common Equity
279.1303.13571.55332.21277.42243.17
Shareholders' Equity
279.1303.13571.55332.21277.42243.17
Total Liabilities & Equity
307.37338.02615.89370.03306.78255.25

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
15.1116.8818.8614.4413.271.09
Net Cash (Debt)
244.35270.53541.07316.7265.78228.95
Net Cash Growth
-63.85%-50.00%70.84%19.16%16.09%-13.60%
Net Cash Per Share
11.317.1514.4510.7510.539.81
Filing Date Shares Outstanding
19.6219.7240.5635.9828.5424
Total Common Shares Outstanding
19.8319.5440.5531.8427.5423.97
Working Capital
271.78295.02561.44322.92269.22239.59
Book Value Per Share
14.0715.5114.0910.4310.0710.14
Tangible Book Value
279.1303.13571.55332.21277.42243.17
Tangible Book Value Per Share
14.0715.5114.0910.4310.0710.14
Machinery
-8.737.195.852.971.92
Leasehold Improvements
----0.210.26
SEC Filings: 10-K · 10-Q